Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages Up to 17 years
• All sexes
• Healthy volunteers accepted
• Child

Study population: children recruited by both GPs and paediatricians

Trial locations and contacts

25 sites in 1 country.

About this study

Conditions

Gastroesophageal Reflux

Keywords

gastroesophageal reflux, prevalence, childhood, France

Medical subject headings

Gastroesophageal Reflux

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. assess prevalence of gastrooesophageal reflux during childhood and teenage years in France, particularly 0-1 year-old prevalence and 1-11 year-old prevalence

   Measured: At the end of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted21 May 2008 (estimated)
2. Study startMay 2008
3. Study completionSep 2008

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Gastroesophageal RefluxStudies of the same condition, open and under way.
• More trials run by AstraZenecaThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.